Clinical Trial Update: IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing IMPENDIA-PEN to Dianeal in diabetic patients on CAPD or APD showed improved metabolic control with IMPENDIA-PEN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• End-stage Renal Disease

Drugs mentioned

• Dianeal PD Solution (peritoneal dialysis solution)
• IMPENDIA-PEN

Snippet

Sponsor: Vantive Health LLC | Conditions: ESRD, Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2019-06-03